BETR INVESTOR ALERT: Investigation of Better Home & Finance Holding Company Announced by Holzer & Holzer, LLC

About this update from Betterlife Pharma Inc.

ATLANTA, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Better Home & Finance Holding Company (“Better” or the “Company”) (NASDAQ: BETR) complied with federal securities laws. On May 7, 2026, Better announced its first quarter 2026 results and provided second quarter guidance. During Better’s earnings call the CEO said that “We expect funded loan volume of approximately $1.65 billion, representing approximately 37% year-over-year growth, slower than what we had originally anticipated going into Q2.” He also indicated that achieving the Company’s $1 billion monthly funded volume target is likely going to be deferred. On this news, the price of the Company’s stock dropped.  If you purchased Better stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at [email protected] or Joshua Karr, Esq. at  [email protected] , call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com/case/better-home-finance/ to discuss your legal rights.   Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, 2023 and 2025, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com , and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.      CONTACT:   Corey Holzer, Esq. (888) 508-6832 (toll-free) [email protected]

View stock analysis, news, and events for Betterlife Pharma Inc.